top of page
Additional Reading
"Once-Weekly Semaglutide in Adults with Overweight or Obesity"
"Efficacy and safety of semaglutide 2.4 mg for weight loss in overweight or obese adults without diabetes: An updated systematic review and meta-analysis including the 2-year STEP 5 trial"
"New Science Suggests Semaglutide Improves CV Outcomes Beyond Weight Loss"
"The Body Weight Reducing Effects of Tirzepatide in People With and Without Type 2 Diabetes: A Review on Efficacy and Adverse Effects"
"Tirzepatide Once Weekly for the Treatment of Obesity"
"Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity"
"Recent study at UC Irvine found that semaglutide medication may benefit 93 million U.S. adults"
bottom of page